158 related articles for article (PubMed ID: 37355720)
1. Endogenous estrogen receptor modulating oxysterols and breast cancer prognosis: Results from the MARIE patient cohort.
Decker NS; Johnson T; Behrens S; Obi N; Kaaks R; Chang-Claude J; Fortner RT
Br J Cancer; 2023 Aug; 129(3):492-502. PubMed ID: 37355720
[TBL] [Abstract][Full Text] [Related]
2. Circulating oxysterols and prognosis among women with a breast cancer diagnosis: results from the MARIE patient cohort.
Decker NS; Johnson T; Vey JA; Le Cornet C; Behrens S; Obi N; Kaaks R; Chang-Claude J; Fortner RT
BMC Med; 2023 Nov; 21(1):438. PubMed ID: 37964298
[TBL] [Abstract][Full Text] [Related]
3. Association of circulating free and total oxysterols in breast cancer patients.
Decker NS; Johnson T; Behrens S; Obi N; Kaaks R; Chang-Claude J; Fortner RT
Clin Chem Lab Med; 2023 Jan; 61(2):285-293. PubMed ID: 36342239
[TBL] [Abstract][Full Text] [Related]
4. Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers.
Farhat GN; Cummings SR; Chlebowski RT; Parimi N; Cauley JA; Rohan TE; Huang AJ; Vitolins M; Hubbell FA; Manson JE; Cochrane BB; Lane DS; Lee JS
J Natl Cancer Inst; 2011 Apr; 103(7):562-70. PubMed ID: 21330633
[TBL] [Abstract][Full Text] [Related]
5. Postdiagnosis circulating osteoprotegerin and TRAIL concentrations and survival and recurrence after a breast cancer diagnosis: results from the MARIE patient cohort.
Le Cornet C; Jung AY; Johnson TS; Behrens S; Obi N; Becher H; Chang-Claude J; Fortner RT
Breast Cancer Res; 2023 Apr; 25(1):42. PubMed ID: 37069615
[TBL] [Abstract][Full Text] [Related]
6. Estrogen metabolism and risk of breast cancer in postmenopausal women.
Fuhrman BJ; Schairer C; Gail MH; Boyd-Morin J; Xu X; Sue LY; Buys SS; Isaacs C; Keefer LK; Veenstra TD; Berg CD; Hoover RN; Ziegler RG
J Natl Cancer Inst; 2012 Feb; 104(4):326-39. PubMed ID: 22232133
[TBL] [Abstract][Full Text] [Related]
7. Endogenous estrogens and risk of breast cancer by estrogen receptor status: a prospective study in postmenopausal women.
Zeleniuch-Jacquotte A; Toniolo P; Levitz M; Shore RE; Koenig KL; Banerjee S; Strax P; Pasternack BS
Cancer Epidemiol Biomarkers Prev; 1995 Dec; 4(8):857-60. PubMed ID: 8634657
[TBL] [Abstract][Full Text] [Related]
8. Sex hormone measurements using mass spectrometry and sensitive extraction radioimmunoassay and risk of estrogen receptor negative and positive breast cancer: Case control study in UK Collaborative Cancer Trial of Ovarian Cancer Screening (UKCTOCS).
Fourkala EO; Blyuss O; Field H; Gunu R; Ryan A; Barth J; Jacobs I; Zaikin A; Dawnay A; Menon U
Steroids; 2016 Jun; 110():62-69. PubMed ID: 27091764
[TBL] [Abstract][Full Text] [Related]
9. Association of Circulating Progesterone With Breast Cancer Risk Among Postmenopausal Women.
Trabert B; Bauer DC; Buist DSM; Cauley JA; Falk RT; Geczik AM; Gierach GL; Hada M; Hue TF; Lacey JV; LaCroix AZ; Tice JA; Xu X; Dallal CM; Brinton LA
JAMA Netw Open; 2020 Apr; 3(4):e203645. PubMed ID: 32329771
[TBL] [Abstract][Full Text] [Related]
10. Pre-diagnostic sex hormone levels and survival among breast cancer patients.
Kensler KH; Eliassen AH; Rosner BA; Hankinson SE; Brown M; Tamimi RM
Breast Cancer Res Treat; 2019 Apr; 174(3):749-758. PubMed ID: 30604001
[TBL] [Abstract][Full Text] [Related]
11. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE
J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513
[TBL] [Abstract][Full Text] [Related]
12. Plasma oxysterol levels in luminal subtype breast cancer patients are associated with clinical data.
Kloudova-Spalenkova A; Ueng YF; Wei S; Kopeckova K; Peter Guengerich F; Soucek P
J Steroid Biochem Mol Biol; 2020 Mar; 197():105566. PubMed ID: 31874216
[TBL] [Abstract][Full Text] [Related]
13. Circulating steroid hormone levels and risk of breast cancer for postmenopausal women.
Baglietto L; Severi G; English DR; Krishnan K; Hopper JL; McLean C; Morris HA; Tilley WD; Giles GG
Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):492-502. PubMed ID: 20086116
[TBL] [Abstract][Full Text] [Related]
14. Circulating 27-Hydroxycholesterol and Breast Cancer Risk: Results From the EPIC-Heidelberg Cohort.
Lu DL; Le Cornet C; Sookthai D; Johnson TS; Kaaks R; Fortner RT
J Natl Cancer Inst; 2019 Apr; 111(4):365-371. PubMed ID: 30016454
[TBL] [Abstract][Full Text] [Related]
15. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
[TBL] [Abstract][Full Text] [Related]
16. Postmenopausal serum sex steroids and risk of hormone receptor-positive and -negative breast cancer: a nested case-control study.
James RE; Lukanova A; Dossus L; Becker S; Rinaldi S; Tjønneland A; Olsen A; Overvad K; Mesrine S; Engel P; Clavel-Chapelon F; Chang-Claude J; Vrieling A; Boeing H; Schütze M; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Krogh V; Panico S; Tumino R; Sacerdote C; Rodríguez L; Buckland G; Sánchez MJ; Amiano P; Ardanaz E; Bueno-de-Mesquita B; Ros MM; van Gils CH; Peeters PH; Khaw KT; Wareham N; Key TJ; Allen NE; Romieu I; Siddiq A; Cox D; Riboli E; Kaaks R
Cancer Prev Res (Phila); 2011 Oct; 4(10):1626-35. PubMed ID: 21813404
[TBL] [Abstract][Full Text] [Related]
17. The insulin-like growth factor family and breast cancer prognosis: A prospective cohort study among postmenopausal women in Denmark.
Kalledsøe L; Dragsted LO; Hansen L; Kyrø C; Grønbæk H; Tjønneland A; Olsen A
Growth Horm IGF Res; 2019 Feb; 44():33-42. PubMed ID: 30622040
[TBL] [Abstract][Full Text] [Related]
18. CYP27A1 expression is associated with risk of late lethal estrogen receptor-positive breast cancer in postmenopausal patients.
Kimbung S; Inasu M; Stålhammar T; Nodin B; Elebro K; Tryggvadottir H; Ygland Rödström M; Jirström K; Isaksson K; Jernström H; Borgquist S
Breast Cancer Res; 2020 Nov; 22(1):123. PubMed ID: 33176848
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer.
Hosoda M; Yamamoto M; Nakano K; Hatanaka KC; Takakuwa E; Hatanaka Y; Matsuno Y; Yamashita H
Breast Cancer Res Treat; 2014 Apr; 144(2):249-61. PubMed ID: 24549642
[TBL] [Abstract][Full Text] [Related]
20. Sex hormones, risk factors, and risk of estrogen receptor-positive breast cancer in older women: a long-term prospective study.
Cummings SR; Lee JS; Lui LY; Stone K; Ljung BM; Cauleys JA
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1047-51. PubMed ID: 15894651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
